Bing Xiu
Impact in
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Lymphoma Diagnosis and Treatment 10
- Oncology 8
- CAR-T cell therapy research 4
- Viral-associated cancers and disorders 2
- Co-authors
- Aibin Liang (20 shared papers)Wenjun Zhang (10 shared papers)Anne J. Novak (3 shared papers)Stephen M. Ansell (3 shared papers)Steven C. Ziesmer (3 shared papers)Deanna M. Grote (3 shared papers)Yi-Qing Qu (1 shared paper)Anmei Deng (1 shared paper)
- Journals
- Blood (2 papers)Frontiers in Genetics (1 paper)Clinical Cancer Research (1 paper)Medicine (1 paper)Diagnostic Cytopathology (1 paper)
- Partner nations
- ChinaUnited StatesIsrael
In The Last Decade
Bing Xiu
22 papers receiving 364 citations
Peers
Comparison fields: 5 of 53
- Pathology and Forensic Medicine 114
- Oncology 172
- Drug Discovery 1
- Immunology 108
- Cancer Research 61
Countries citing papers authored by Bing Xiu
This map shows the geographic impact of Bing Xiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Xiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Xiu more than expected).
Fields of papers citing papers by Bing Xiu
This network shows the impact of papers produced by Bing Xiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Xiu. The network helps show where Bing Xiu may publish in the future.
Co-authors
The 25 scholars most cited alongside Bing Xiu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 82 | |
| 2 | 2011 | 61 | |
| 3 | 2013 | 60 | |
| 4 | 2017 | 45 | |
| 5 | Circular RNA profile of acute myeloid leukaemia indicates circular RNA annexin A2 as a potential biomarker and therapeutic target for acute myeloid leukaemia. | 2020 | 24 |
| 6 | 2020 | 18 | |
| 7 | Up-regulation of VEGF and its receptor in refractory leukemia cells. | 2015 | 17 |
| 8 | 2012 | 14 | |
| 9 | 2013 | 10 | |
| 10 | 2021 | 5 | |
| 11 | 2013 | 5 | |
| 12 | 2020 | 5 | |
| 13 | 2024 | 4 | |
| 14 | 2017 | 4 | |
| 15 | 2024 | 3 | |
| 16 | 2012 | 2 | |
| 17 | 2022 | 2 | |
| 18 | 2025 | 1 | |
| 19 | 2023 | 1 | |
| 20 | [Study of hypermethylation of SOCS gene in typical myeloproliferative disease]. | 2011 | 1 |
About Bing Xiu
Bing Xiu is a scholar working on Pathology and Forensic Medicine, Oncology, Molecular Biology, Hematology and Genetics, having authored 27 papers that have together received 366 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (10 papers), CAR-T cell therapy research (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Lung Cancer Treatments and Mutations (3 papers), Glycosylation and Glycoproteins Research (2 papers), RNA Interference and Gene Delivery (2 papers), Viral-associated cancers and disorders (2 papers) and CNS Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (114 citations), Oncology (172 citations), Drug Discovery (1 citation), Immunology (108 citations) and Cancer Research (61 citations). Bing Xiu has collaborated with scholars based in China, United States and Israel. Frequent co-authors include Aibin Liang, Wenjun Zhang, Anne J. Novak, Stephen M. Ansell, Steven C. Ziesmer, Deanna M. Grote, Yi-Qing Qu, Anmei Deng, Huazong Zeng and Kay M. Ristow. Their work appears in journals such as Blood, Frontiers in Genetics, Clinical Cancer Research, Medicine and Diagnostic Cytopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.